[Federal Register Volume 69, Number 215 (Monday, November 8, 2004)]
[Notices]
[Page 64778]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24842]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Renewals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of certain FDA advisory committees by the Commissioner of Food 
and Drugs (the Commissioner). The Commissioner has determined that it 
is in the public interest to renew the charters of the committees 
listed in table 1 of this document for an additional 2 years beyond 
charter expiration date. The new charters will be in effect until the 
dates of expiration listed in table 1. This notice is issued under the 
Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 
U.S.C. app. 2)).

DATES: Authority for these committees will expire on the dates 
indicated in table 1 of this document unless the Commissioner formally 
determines that renewal is in the public interest.

                                Table 1.
------------------------------------------------------------------------
                Name of committee                   Date of expiration
------------------------------------------------------------------------
Anesthetic and Life Support Drugs Advisory        May 1, 2006.
 Committee.
Blood Products Advisory Committee...............  May 13, 2006.
Pulmonary-Allergy Drugs Advisory Committee......  May 30, 2006.
Drug Safety and Risk Management Advisory          May 31, 2006.
 Committee.
Science Advisory Board to the National Center     June 2, 2006.
 for Toxicological Research.
Peripheral and Central Nervous System Drugs       June 4, 2006.
 Advisory Committee.
Psychopharmacologic Drugs Advisory Committee....  June 4, 2006.
Transmissible Spongiform Encephalopathies         June 9, 2006.
 Advisory Committee.
Science Board to the Food and Drug                June 26, 2006.
 Administration.
Allergenic Products Advisory Committee..........  July 9, 2006.
Cardiovascular and Renal Drugs Advisory           August 27, 2006.
 Committee.
Endocrinologic and Metabolic Drugs Advisory       August 27, 2006.
 Committee.
Oncologic Drugs Advisory Committee..............  September 1, 2006.
Anti-Infective Drugs Advisory Committee.........  October 7, 2006.
Dermatologic and Ophthalmic Drugs Advisory        October 7, 2006.
 Committee.
Cellular, Tissue, and Gene Therapies Advisory     October 28, 2006.
 Committee (formerly Biological Response
 Modifiers Advisory Committee).
------------------------------------------------------------------------


FOR FURTHER INFORMATION CONTACT: Linda A. Sherman, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

    Dated: October 29, 2004.
Sheila Dearybury Walcoff,
Associate Commissioner for External Relations.
[FR Doc. 04-24842 Filed 11-5-04; 8:45 am]
BILLING CODE 4160-01-S